Literature DB >> 25496729

Characterization of the endemic equilibrium and response to mutant injection in a multi-strain disease model.

Tomás Aquino1, Diogo Bolster2, Ana Nunes3.   

Abstract

We explore a model of an antigenically diverse infection whose otherwise identical strains compete through cross-immunity. We assume that individuals may produce upon infection different numbers of antibody types, each of which matches the antigenic configuration of a particular epitope, and that one matching antibody type grants total immunity against a challenging strain. In order to reduce the number of equations involved in the analytic description of the dynamics, we follow the strategy proposed by Kryazhimskiy et al. (2007) and apply a low-order closure reminiscent of a pair approximation. Using this approximation, we go beyond the numerical studies of Kryazhimskiy et al. (2007) and explore the analytic properties of the ensuing model in the absence of mutation. We characterize its endemic equilibrium, comparing with the results of agent based simulations of the full model to assess the performance of the closure assumption. We show that a particular choice of immune response leads to a degenerate endemic equilibrium, where different strain prevalences may exist, breaking the symmetry of the model. Finally we study the behavior of the system under the injection of mutant strains. We find that the build up of diversity from a single founding strain is extremely unlikely for different choices of the population׳s immune response.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Keywords:  Mathematical epidemiology; Strain competition and evolution; Strain cross-immunity

Mesh:

Year:  2014        PMID: 25496729     DOI: 10.1016/j.jtbi.2014.12.001

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  1 in total

1.  Host immunity and pathogen diversity: A computational study.

Authors:  Tomás Aquino; Ana Nunes
Journal:  Virulence       Date:  2016       Impact factor: 5.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.